眼科黏彈性物質市場規模、佔有率及成長分析（按產品類型、應用、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，全球眼科黏彈性物質市場規模將達到 117.2 億美元，到 2025 年將成長至 130.8 億美元，到 2033 年將成長至 314.7 億美元，在預測期（2026-2033 年）內複合年成長率為 11.6%。

全球眼科黏彈性器材市場正經歷顯著成長，這主要得益於微創眼科手術需求的不斷成長以及黏彈性材料配方技術的進步。隨著白內障、青光眼和老齡化黃斑部病變等眼科疾病的日益增多，使用這些器械對於確保有效的手術效果和保護患者視力至關重要。眼科手術在全球的擴張是推動市場發展的關鍵因素，因為眼科黏彈劑在維持眼部空間、穩定眼部組織和保護眼部組織方面發揮著至關重要的作用。此外，眼科醫療服務的可及性提高和眼部健康意識的增強，以及黏彈性自適應器械在角膜移植等複雜手術中簡化手術流程的廣泛應用，也推動了市場成長。

眼科黏彈劑市場按產品類型、應用、最終用戶和地區進行細分。依產品類型分類，眼科黏彈劑分為凝聚型黏彈劑和分散型黏彈劑。依應用分類，眼科黏彈劑分為白內障、青光眼、角膜移植和玻璃體視網膜手術。依最終使用者分類，眼科黏彈劑分為醫院、眼科診所和其他機構。依地區分類，眼科黏彈劑分為北美、亞太、歐洲、拉丁美洲以及中東和非洲。

全球眼科黏彈性器材市場促進因素

白內障、青光眼和老齡化黃斑部病變等眼科疾病的日益增多，顯著推動了全球眼科黏彈性物質市場的成長。人口老化和生活方式的改變等因素加劇了這些疾病的盛行率，導致手術干預日益頻繁。眼科黏彈性物質在這些手術中發揮著至關重要的作用，它們能夠保護脆弱的眼部組織、維持眼內空間並提高手術效率。隨著需要接受此類手術治療的患者數量不斷增加，對優質黏彈性物質的需求預計將進一步推動市場發展。

全球眼科黏彈性器材市場面臨的限制因素

全球眼科黏彈性物質市場面臨許多限制因素，其中高成本尤其突出，特別是那些採用創新材料和具有更高生物相容性的產品。這一經濟壁壘為新興市場和醫療預算有限的地區的醫院和診所帶來了挑戰。因此，中低收入地區的患者可能難以獲得這些先進產品，主要原因是經濟承受能力不足。高昂的價格分佈可能會限制這些技術在醫療資源匱乏地區的普及和使用，從而阻礙市場成長，進而直接影響整體市場滲透率。

全球眼科黏彈性器材市場趨勢

人工智慧 (AI) 和數位技術在眼科手術流程中的應用是全球眼科黏彈劑市場的一大趨勢。這種融合透過人工智慧驅動的診斷影像和手術輔助，增強了術前規劃、術中引導和術後護理。這些進步提高了黏彈劑應用的精準度，從而最大限度地降低手術風險並改善治療效果。隨著這些技術的不斷發展，與先進手術系統相容的黏彈劑的應用顯著增加。隨著醫療專業人員尋求提高眼科手術的品質和效率，這種技術協同效應有望推動市場成長。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球眼科黏彈性物質市場規模（按產品類型和複合年成長率分類）（2026-2033 年）

• 疏水性
• 親水性
• 複雜類型

全球眼科黏彈性物質市場規模（按類型和複合年成長率分類）（2026-2033 年）

• 黏彈性眼科用黏劑
• 可分散眼科黏彈性劑

全球眼科黏彈性劑市場規模（按成分和複合年成長率分類）（2026-2033 年）

• 透明質酸鈉
• 硫酸軟骨素
• 羥丙基甲基纖維素

全球眼科黏彈性物質市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 白內障手術
• 角膜手術
• 青光眼手術
• 屈光矯正手術

全球眼科黏彈性物質市場規模（按最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院
• 門診手術中心
• 眼科診所

全球眼科黏彈性劑市場規模（按製劑類型和複合年成長率分類）（2026-2033 年）

• 一次使用
• 多用途

全球眼科黏彈性物質市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Alcon（Switzerland）
• Bausch+Lomb（Bausch Health）（USA）
• Carl Zeiss Meditec AG（Germany）
• Johnson & Johnson Vision（USA）
• Rayner Intraocular Lenses Limited（UK）
• Bohus Biotech AB（Sweden）
• Lifecore Biomedical LLC（USA）
• Hoya Corporation（Japan）
• Santen Pharmaceutical Co., Ltd.（Japan）
• Croma-Pharma GmbH（Austria）
• Eyekon Medical Inc.（USA）
• RUMEX International Co.（USA）
• Ziemer Ophthalmic Systems AG（Switzerland）
• Ophtechnics Unlimited（India）
• Haohai Biological Technology（China）
• Amring Pharmaceutical Inc.（USA）
• Truviz Ophthalmic（USA）
• Cima Technology Inc.（USA）

結論與建議

Global Ophthalmic Viscoelastic Devices Market size was valued at USD 11.72 Billion in 2024 and is poised to grow from USD 13.08 Billion in 2025 to USD 31.47 Billion by 2033, growing at a CAGR of 11.6% during the forecast period (2026-2033).

The global ophthalmic viscoelastic devices market is experiencing significant growth, driven by the increasing demand for minimally invasive eye surgeries and innovations in viscoelastic material formulations. A rise in eye disorders, such as cataracts, glaucoma, and age-related macular degeneration, necessitates the use of these devices to ensure effective surgical outcomes and preserve patient vision. The expansion of ophthalmic surgical procedures worldwide is a crucial factor contributing to market development, as ophthalmic viscoelastic devices play a vital role in maintaining space, stabilizing, and protecting ocular tissues. Furthermore, enhanced access to ophthalmic care and heightened awareness of ocular health are fostering market growth, along with the popularity of viscoadaptive devices that streamline surgical processes in complex cases like corneal transplantation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ophthalmic Viscoelastic Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ophthalmic Viscoelastic Devices Market Segments Analysis

The ophthalmic viscoelastic devices market is segmented into product type, application, end user and region. Based on product type, the market is segmented into cohesive ophthalmic viscoelastic and dispersive ophthalmic viscoelastic. Based on application, the market is segmented into cataract, glaucoma, corneal transplant and vitreoretinal surgery. Based on end user, the market is segmented into hospitals, ophthalmic clinics and others. Based on region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Driver of the Global Ophthalmic Viscoelastic Devices Market

The rise in eye-related conditions like cataracts, glaucoma, and age-related macular degeneration significantly contributes to the growth of the Global Ophthalmic Viscoelastic Devices market. Factors such as an aging population and various lifestyle choices are leading to a higher prevalence of these diseases, which frequently require surgical interventions. Ophthalmic viscoelastic devices play a crucial role in these procedures by safeguarding delicate ocular tissues, preserving intraocular space, and enhancing surgical efficiency. As the volume of patients needing these surgical solutions increases, the demand for superior viscoelastic devices is set to escalate, driving the market forward.

Restraints in the Global Ophthalmic Viscoelastic Devices Market

The Global Ophthalmic Viscoelastic Devices market faces a notable constraint due to the elevated costs associated with advanced devices, particularly those utilizing innovative materials and improved biocompatibility. This financial barrier poses challenges for hospitals and clinics located in emerging markets or areas with constrained healthcare budgets. Consequently, patients in low and middle-income regions may find it difficult to access these advanced products, primarily due to affordability concerns. This limitation directly affects the overall market penetration, as the high price point can restrict the availability and usage of these technologies in underserved regions, hindering market growth opportunities.

Market Trends of the Global Ophthalmic Viscoelastic Devices Market

The Global Ophthalmic Viscoelastic Devices market is witnessing a significant trend toward the integration of artificial intelligence and digital technologies within surgical workflows. This integration enhances preoperative planning, intraoperative guidance, and postoperative care by utilizing AI-driven imaging and surgical assistance. Such advancements foster precision in the application of viscoelastic devices, consequently minimizing surgical risks and improving outcomes. As these technologies continue to evolve, there is a marked increase in the adoption of viscoelastic devices that are compatible with sophisticated surgical systems. This technological synergy is poised to drive market growth as practitioners seek to enhance the quality and efficiency of ophthalmic procedures.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Ophthalmic Viscoelastic Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Hydrophobic
• Hydrophilic
• Combination

Global Ophthalmic Viscoelastic Devices Market Size by Type & CAGR (2026-2033)

• Market Overview
• Cohesive Ophthalmic Viscoelastic
• Dispersive Ophthalmic Viscoelastic

Global Ophthalmic Viscoelastic Devices Market Size by Composition & CAGR (2026-2033)

• Market Overview
• Sodium Hyaluronate
• Chondroitin Sulfate
• Hydroxypropyl Methylcellulose

Global Ophthalmic Viscoelastic Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Cataract Surgery
• Corneal Surgery
• Glaucoma Surgery
• Refractive Surgery

Global Ophthalmic Viscoelastic Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Ophthalmic Clinics

Global Ophthalmic Viscoelastic Devices Market Size by Formulation Type & CAGR (2026-2033)

• Market Overview
• Single-Use
• Multi-Use

Global Ophthalmic Viscoelastic Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Type, Composition, Application, End User, Formulation Type)
  • US
  • Canada
• Europe (Product Type, Type, Composition, Application, End User, Formulation Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type, Composition, Application, End User, Formulation Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type, Composition, Application, End User, Formulation Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type, Composition, Application, End User, Formulation Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Alcon (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch + Lomb (Bausch Health) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss Meditec AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Vision (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rayner Intraocular Lenses Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bohus Biotech AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifecore Biomedical LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoya Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Santen Pharmaceutical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Croma-Pharma GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eyekon Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RUMEX International Co. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ziemer Ophthalmic Systems AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ophtechnics Unlimited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haohai Biological Technology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amring Pharmaceutical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Truviz Ophthalmic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cima Technology Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations